Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion type Assertion NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_head.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion description "[We tested the association of the presence of the ABCB1 (C/T) T-allele, CYP2C19*2 (G/A) A-allele, or CYP2C19*17 (C/T) T-allele with the primary end point of the need of clinically-driven target lesion revascularization (TLR) and the secondary end points of major adverse cardiovascular events (MACE; including death, myocardial infarction [MI], and TLR) at 1 year in a high-risk population of 928 patients with acute MI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_provenance.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion evidence source_evidence_literature NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_provenance.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion SIO_000772 20826260 NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_provenance.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion wasDerivedFrom befree-2016 NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_provenance.
- NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_assertion wasGeneratedBy ECO_0000203 NP838022.RAwvyFiB2N9SIQqnl3FO0YAQauwTB06AzYw7VMiO2eU3o130_provenance.